Activated Rispharm, the first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients, will be introduced at Pharmapack 2022 (18th & 19th May in Paris). Developed in a strategic commercial partnership between Berry Global, a leading provider of innovative packaging and engineered products, and Pylote, a key player in the industrial mineral chemistry, the solution will be presented on the Berry Global stand (A60). Activated Rispharm will also be submitted into the 2022 Pharmapack Awards and will be seen at the exhibition’s Innovation Gallery.
Activated Rispharm is a new multidose eye dropper with nozzle and cap activated to kill bacteria and viruses continuously to deliver hygienic doses at each use and, thus, to reduce infection risks. The product delivers unique antimicrobial protection properties resulting from the combination of Pylote’s expertise in mineral chemistry that helps protect patients/users from the risk of microbial infections, with Berry Global ’s expertise in sustainable healthcare packaging. Pylote’s patented mineral technology – microspheres – is embedded into the resin masterbatch, and is fully recyclable, thus supporting efforts towards sustainability.
Among the advantages mentioned by the company are:
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy